Publications Group Pruschy

The novel microtubule targeting agent BAL101553 in combination with radiotherapy in treatment-refractory tumor models. Sharma A, Broggini-Tenzer A, Vuong V, Messikommer A, Nytko KJ, Guckenberger M, Bachmann F, Lane HA, Pruschy M. Radiother Oncol. 2017; 124(3):433-438.

Secretome Signature Identifies ADAM17 as Novel Target for Radiosensitization of Non-Small Cell Lung Cancer.Sharma A, Bender S, Zimmermann M, Riesterer O, Broggini-Tenzer A, Pruschy MN. Clin Cancer Res. 2016; 22(17):4428-39.

Combined treatment strategies for microtubule stabilizing agent-resistant tumors. Broggini-Tenzer A, Sharma A, Nytko KJ, Bender S, Vuong V, Orlowski K, Hug D, O'Reilly T, Pruschy M. J Natl Cancer Inst. 2015; 107(4). pii: dju504.

Differential DNA repair pathway choice in cancer cells after proton- and photon-irradiation.Fontana AO, Augsburger MA, Grosse N, Guckenberger M, Lomax AJ, Sartori AA, Pruschy MN. Radiother Oncol. 2015; 116(3):374-80.

Ionizing radiation antagonizes tumor hypoxia induced by antiangiogenic treatment.
Riesterer O, Honer M, Jochum W, Oehler C, Ametamey S, Pruschy M. Clin Cancer Res. 2006; 12(11 Pt 1):3518-24